Clinical Trials Directory

Trials / Completed

CompletedNCT02970617

Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients

Are Last Impressions Lasting Impressions? Intervention of Ringing a Bell at the End of Cancer Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies how well ringing a bell on the final day of radiation therapy works in improving the memory of distress in cancer patients. Ringing a bell on the final day of radiation therapy may improve the memory of how painful the treatment was.

Detailed description

PRIMARY OBJECTIVES: I. To determine if the simple act of ringing a bell at the end of radiotherapy can improve the retrospective evaluation of distress due to radiotherapy and other prior cancer therapy. SECONDARY OBJECTIVES: I. To measure the severity of patients' memory of distress from cancer treatment. II. To assess the relationship between anxiety to actual distress and to remembered distress. III. To assess the relationship between optimism-pessimism personality to actual distress and to remembered distress. IV. To assess patient's cognitive dissonance reduction to actual distress and to remembered distress. OUTLINE: Patients are assigned to 1 of 2 groups. GROUP A (No bell ringing): Patients undergo standard of care radiation therapy with or without chemotherapy. GROUP B (Bell ringing): On the final day of standard of care radiation therapy, patients ring a bell in the clinic. After completion of study, patients are followed up for 7 months.

Conditions

Interventions

TypeNameDescription
OTHERMemory InterventionRing bell after final radiation treatment
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2016-08-15
Primary completion
2018-11-15
Completion
2018-11-15
First posted
2016-11-22
Last updated
2025-10-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02970617. Inclusion in this directory is not an endorsement.